Targeting A20 Decreases Glioma Stem Cell Survival and Tumor Growth

Anita B. Hjelmeland; Qiulian Wu; Sarah Wickman; Christine Eyler; John Heddleston; Qing Shi; Justin D. Lathia; Jennifer MacSwords; Jeongwu Lee; Roger E. McLendon; Jeremy N. Rich

doi:10.1371/journal.pbio.1000319

Loading metrics

Open Access

Peer-reviewed

Research Article

Targeting A20 Decreases Glioma Stem Cell Survival and Tumor Growth

Anita B. Hjelmeland ,

* E-mail: hjelmea@ccf.org (ABH); richj@ccf.org (JNR)

Affiliation Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America
⨯
Qiulian Wu,

Affiliation Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America
⨯
Sarah Wickman,

Affiliation Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America
⨯
Christine Eyler,

Affiliations Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America, Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America
⨯
John Heddleston,

Affiliation Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America
⨯
Qing Shi,

Affiliation Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America
⨯
Justin D. Lathia,

Affiliation Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America
⨯
Jennifer MacSwords,

Affiliation Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America
⨯
Jeongwu Lee,

Affiliation Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America
⨯
Roger E. McLendon,

Affiliation Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States of America
⨯
Jeremy N. Rich

* E-mail: hjelmea@ccf.org (ABH); richj@ccf.org (JNR)

Affiliation Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America
⨯

Targeting A20 Decreases Glioma Stem Cell Survival and Tumor Growth

Anita B. Hjelmeland,
Qiulian Wu,
Sarah Wickman,
Christine Eyler,
John Heddleston,
Qing Shi,
Justin D. Lathia,
Jennifer MacSwords,
Jeongwu Lee,
Roger E. McLendon

Published: February 23, 2010
https://doi.org/10.1371/journal.pbio.1000319

Reader Comments (1)

Post a new comment on this article

0 Responses

04 May 2010
00:53 GMT
Most Recent

Publisher's Note: Error in the Immunofluorescence Staining section Posted by PLOSBiology on 04 May 2010 at 00:53 GMT

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Glioma cells
Is the Subject Area "Glioma cells" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Cancer stem cells
Is the Subject Area "Cancer stem cells" applicable to this article?

Thanks for your feedback.
Glioma
Is the Subject Area "Glioma" applicable to this article?

Thanks for your feedback.
Tumor stem cells
Is the Subject Area "Tumor stem cells" applicable to this article?

Thanks for your feedback.
Neurospheres
Is the Subject Area "Neurospheres" applicable to this article?

Thanks for your feedback.
Stem cell therapy
Is the Subject Area "Stem cell therapy" applicable to this article?

Thanks for your feedback.